GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness 20 April
GH Research Announces Publication of Phase 2b Results for Mebufotenin in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD 25 March
